The University of Texas MD Anderson Cancer Center, together with Gustave Roussy, initiated the WIN Consortium
The University of Texas MD Anderson Cancer Center is one of the world’s most respected centers devoted exclusively to cancer patient care, research, education and prevention. MD Anderson has treated more than one million cancer patients since it opened in 1944. At MD Anderson, important scientific knowledge gained in the laboratory is rapidly translated to clinical care. In FY14, MD Anderson invested more than $735 million in research, an increase of 35% in the past five years.
MD Anderson's Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy is an international center of clinical excellence focusing on using the latest advances in genetic information to develop safe, more effective treatments for patients on a case-by-case basis.